bioRxivPharmacology & ToxicologyPreprint
Liver-Chip: Reproducing Human and Cross-Species Toxicities
K.-J. Jang, M. Otieno, J. Ronxhi, H.-K. Lim, L. Ewart, K. Kodella, D. Petropolis, G. Kulkarni, J. Rubins, D. Conegliano, J. Nawroth, D. Simic, W. Lam, M. Singer, E. Barale, B. Singh, M. Sonee, A. Streeter, C. Manthey, B. Jones, A. Srivastava, L. Andersson, D. Williams, H. Park, R. Barrile, , G. Hamilton
Abstract
Nonclinical rodent and non-rodent toxicity models used to support clinical trials of candidate drugs may produce discordant results or fail to predict complications in humans contributing to drug failures in the clinic. Here we applied microengineered Organ-on-Chip (Organ-Chip) technology to design rat, dog, and human Liver-Chips containing species-specific primary hepatocytes interfaced with liver sinusoidal endothelial cells, with or without Kupffer cells and hepatic stellate cells, cultured under physiological fluid flow. The Liver-Chips detected diverse phenotypes of liver toxicity including hepatocellular injury, steatosis, cholestasis, and fibrosis as well as species-specific toxicities when treated with tool compounds. Multi-species Liver-Chips may provide a useful platform for prediction of liver toxicity and inform human relevance of liver toxicities detected in animal studies to better determine safety and human risk.\n\nOne Sentence SummaryMicroengineered Organ-Chip technology has been used to design rat, dog and human Liver-Chips that recapitulate species-specific liver toxicities.
- organism: rat
- organism: human
- organism: mouse
- research focus: drug response / drug discovery
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Qualifying a human Liver-Chip for predictive toxicology: Performance assessment and economic implications
L. Ewart, A. Apostolou, … D. Levner·bioRxiv·Dec 14, 2021
- A High-Throughput Microphysiological Liver Chip System to Model Direct and Idiosyncratic Drug-Induced Liver Injury Using Human Liver Organoids
C. J. Zhang, S. R. Meyer, … J. Z. Sexton·bioRxiv·Dec 1, 2023
- A Human Liver Organoid Screening Platform for DILI Risk Prediction
C. J. Zhang, S. R. Meyer, … J. Z. Sexton·bioRxiv·Aug 26, 2021
- Introducing CELLBLOKS: a novel organ-on-a-chip platform allowing a plug-and-play approach towards building organotypic models
V. Llabjani, M. R. Siddique, … A. Raza·bioRxiv·Apr 5, 2022
- Novel hepatocyte-like liver organoids recapitulate crucial mature hepatic functions
Arif Ibrahim Ardisasmita, Indi P. Joore, … Sabine A. Fuchs·bioRxiv·Oct 29, 2024
- Modeling alcoholic liver disease in a human Liver-Chip
J. C. Nawroth, D. B. Petropolis, … K. Karalis·bioRxiv·Jul 14, 2020